Cargando…
Advances in postoperative adjuvant therapy for primary liver cancer
Hepatocellular carcinoma (HCC) is a highly heterogeneous, invasive, and conventional chemotherapy-insensitive tumor with unique biological characteristics. The main methods for the radical treatment of HCC are surgical resection or liver transplantation. However, recurrence rates are as high as 50%...
Autores principales: | Zeng, Zhi-Ming, Mo, Ning, Zeng, Jie, Ma, Fu-Chao, Jiang, Yan-Feng, Huang, Hua-Sheng, Liao, Xi-Wen, Zhu, Guang-Zhi, Ma, Jie, Peng, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516643/ https://www.ncbi.nlm.nih.gov/pubmed/36187393 http://dx.doi.org/10.4251/wjgo.v14.i9.1604 |
Ejemplares similares
-
Progression-free survival of up to 8 months of an advanced intrahepatic cholangiocarcinoma patient treated with apatinib: a case report
por: Ma, Fu-Chao, et al.
Publicado: (2017) -
Postoperative Adjuvant Treatment Strategy for Locally Advanced Rectal Cancer after Neoadjuvant Treatment
por: Li, Jia-yi, et al.
Publicado: (2021) -
Which Definition of Upper Rectal Cancer Is Optimal in Selecting Stage II or III Rectal Cancer Patients to Avoid Postoperative Adjuvant Radiation?
por: Gao, Xian Hua, et al.
Publicado: (2021) -
Inflammatory myofibroblastic tumor of the prostate after transurethral resection of the prostate with negative expression of anaplastic lymphoma kinase: a case report
por: Zeng, Jie, et al.
Publicado: (2018) -
The efficacy and safety of postoperative adjuvant transarterial embolization and radiotherapy in hepatocellular carcinoma patients with portal vein tumor thrombus
por: Bai, Tao, et al.
Publicado: (2016)